When you inject this medication, it binds to GLP-1 receptors throughout your gastrointestinal tract, slowing the rate at which your stomach empties food into your small intestine
I know I could be those things
From a research classification standpoint, Retatrutide is a synthetic peptide engineered to interact with multiple metabolic signaling pathways that are commonly studied in laboratory models examining energy balance, nutrient signaling, and appetiterelated mechanisms
GLP-1R may ameliorate these conditions by improving insulin signaling and reducing insulin resistance in the brain
The most advanced of these, CagriSema (Novo Nordisk) is at Phase III and combines cagrilintide, a lipidated amylin analogue with semaglutide
However, this should not be interpreted to mean that the active ingredient is safe or available for patients outside clinical trials